Labruna Giuseppe, Nanayakkara Merlin, Pagliuca Chiara, Nunziato Marcella, Iaffaldano Laura, D'Argenio Valeria, Colicchio Roberta, Budelli Andrea L, Nigro Roberto, Salvatore Paola, Barone Maria Vittoria, Sacchetti Lucia
IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) SDN, Naples, Italy.
Dipartimento di Scienze Mediche Traslazionali and European Laboratory for the Investigation of Food Induced Disease (ELFID), Università degli Studi di Napoli Federico II, Naples, Italy.
Cell Microbiol. 2019 Aug;21(8):e13035. doi: 10.1111/cmi.13035. Epub 2019 May 20.
We previously identified a Neisseria flavescens strain in the duodenum of celiac disease (CD) patients that induced immune inflammation in ex vivo duodenal mucosal explants and in CaCo-2 cells. We also found that vesicular trafficking was delayed after the CD-immunogenic P31-43 gliadin peptide-entered CaCo-2 cells and that Lactobacillus paracasei CBA L74 (L. paracasei-CBA) supernatant reduced peptide entry. In this study, we evaluated if metabolism and trafficking was altered in CD-N. flavescens-infected CaCo-2 cells and if any alteration could be mitigated by pretreating cells with L. paracasei-CBA supernatant, despite the presence of P31-43. We measured CaCo-2 bioenergetics by an extracellular flux analyser, N. flavescens and P31-43 intracellular trafficking by immunofluorescence, cellular stress by TBARS assay, and ATP by bioluminescence. We found that CD-N. flavescens colocalised more than control N. flavescens with early endocytic vesicles and more escaped autophagy thereby surviving longer in infected cells. P31-43 increased colocalisation of N. flavescens with early vesicles. Mitochondrial respiration was lower (P < .05) in CD-N. flavescens-infected cells versus not-treated CaCo-2 cells, whereas pretreatment with L. paracasei-CBA reduced CD-N. flavescens viability and improved cell bioenergetics and trafficking. In conclusion, CD-N. flavescens induces metabolic imbalance in CaCo-2 cells, and the L. paracasei-CBA probiotic could be used to correct CD-associated dysbiosis.
我们之前在乳糜泻(CD)患者的十二指肠中鉴定出一株微黄奈瑟菌,该菌株可在离体十二指肠黏膜外植体和人结肠腺癌细胞(CaCo-2细胞)中诱导免疫炎症。我们还发现,具有CD免疫原性的P31 - 43麦醇溶蛋白肽进入CaCo-2细胞后,囊泡运输会延迟,并且副干酪乳杆菌CBA L74(副干酪乳杆菌-CBA)的上清液可减少肽的进入。在本研究中,我们评估了在感染了CD-微黄奈瑟菌的CaCo-2细胞中,代谢和运输是否发生改变,以及尽管存在P31 - 43,用副干酪乳杆菌-CBA上清液预处理细胞是否可以减轻任何改变。我们通过细胞外通量分析仪测量CaCo-2细胞的生物能量学,通过免疫荧光测量微黄奈瑟菌和P31 - 43的细胞内运输,通过硫代巴比妥酸反应物(TBARS)测定法测量细胞应激,并通过生物发光测量三磷酸腺苷(ATP)。我们发现,与对照微黄奈瑟菌相比,CD-微黄奈瑟菌与早期内吞小泡的共定位更多,并且更多地逃避自噬,从而在感染细胞中存活更长时间。P31 - 43增加了微黄奈瑟菌与早期小泡的共定位。与未处理的CaCo-2细胞相比,感染CD-微黄奈瑟菌的细胞中线粒体呼吸较低(P < 0.05),而用副干酪乳杆菌-CBA预处理可降低CD-微黄奈瑟菌的活力,并改善细胞生物能量学和运输。总之,CD-微黄奈瑟菌在CaCo-2细胞中诱导代谢失衡,副干酪乳杆菌-CBA益生菌可用于纠正与CD相关的生态失调。